FOXC1: an emerging marker and therapeutic target for cancer

被引:0
|
作者
B Han
N Bhowmick
Y Qu
S Chung
A E Giuliano
X Cui
机构
[1] Samuel Oschin Comprehensive Cancer Institute,Department of Surgery
[2] Cedars-Sinai Medical Center,Department of Medicine
[3] Samuel Oschin Comprehensive Cancer Institute,undefined
[4] Cedars-Sinai Medical Center,undefined
来源
Oncogene | 2017年 / 36卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The Forkhead box C1 (FOXC1) transcription factor is involved in normal embryonic development and regulates the development and function of many organs. Most recently, a large body of literature has shown that FOXC1 plays a critical role in tumor development and metastasis. Clinical studies have demonstrated that elevated FOXC1 expression is associated with poor prognosis in many cancer subtypes, such as basal-like breast cancer (BLBC). FOXC1 is highly and specifically expressed in BLBC as opposed to other breast cancer subtypes. Its functions in breast cancer have been extensively explored. This review will summarize current knowledge on the function and regulation of FOXC1 in tumor development and progression with a focus on BLBC, as well as the implications of these new findings in cancer diagnosis and treatment.
引用
收藏
页码:3957 / 3963
页数:6
相关论文
共 50 条
  • [41] Smoking promotes lung cancer progression through the MAPK/FOXC1 pathway
    Wang, Rui
    Cao, Jie
    RESPIROLOGY, 2024, 29 : 52 - 53
  • [42] FGF19 is a target for FOXC1 regulation in ciliary body-derived cells
    Tamimi, Yahya
    Skarie, Jonathan M.
    Footz, Tim
    Berry, Fred B.
    Link, Brian A.
    Walter, Michael A.
    HUMAN MOLECULAR GENETICS, 2006, 15 (21) : 3229 - 3240
  • [43] FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort
    Johnson, Jeff
    Choi, Michael
    Dadmanesh, Farnaz
    Han, Bingchen
    Qu, Ying
    Yu-Rice, Yi
    Zhang, Xiao
    Bagaria, Sanjay
    Taylor, Clive
    Giuliano, Armando E.
    Amersi, Farin
    Cui, Xiaojiang
    ONCOTARGET, 2016, 7 (46) : 75729 - 75738
  • [44] Calreticulin as a marker and therapeutic target for cancer
    Zhang, Meilan
    Xiao, Juan
    Liu, Jiangrong
    Bai, Xue
    Zeng, Xuemei
    Zhang, Zhiwei
    Liu, Feng
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (05) : 1393 - 1404
  • [45] Calreticulin as a marker and therapeutic target for cancer
    Meilan Zhang
    Juan Xiao
    Jiangrong Liu
    Xue Bai
    Xuemei Zeng
    Zhiwei Zhang
    Feng Liu
    Clinical and Experimental Medicine, 2023, 23 : 1393 - 1404
  • [46] Cell surface GRP78: An emerging imaging marker and therapeutic target for cancer
    Farshbaf, Masoud
    Khosroushahi, Ahmad Yari
    Mojarad-Jabali, Solmaz
    Zarebkohan, Amir
    Valizadeh, Hadi
    Walker, Paul R.
    JOURNAL OF CONTROLLED RELEASE, 2020, 328 : 932 - 941
  • [47] BC200 RNA: An Emerging Therapeutic Target and Diagnostic Marker for Human Cancer
    Shin, Heegwon
    Kim, Youngmi
    Kim, Meehyein
    Lee, Younghoon
    MOLECULES AND CELLS, 2018, 41 (12) : 993 - 999
  • [48] The Influence of FOXC1 Gene on Development, Organogenesis, and Functions
    Biyani, Shruti
    Patil, Amol Somaji
    Swami, Vinit
    CLINICAL & TRANSLATIONAL METABOLISM, 2024, 22 (01)
  • [49] DANCR: an emerging therapeutic target for cancer
    Yan, Yuheng
    Shi, Qingmiao
    Yuan, Xin
    Xue, Chen
    Shen, Shen
    He, Yuting
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (07): : 4031 - 4042
  • [50] The proteasome - An emerging therapeutic target in cancer
    Mitchell, BS
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26): : 2597 - 2598